Medtronic
Marketing and Public Relations
OVERVIEW: Medtronic, in collaboration with Clue Digital, executed a successful campaign for its MiniMed 780G, tailored to engage Canada’s Type 1 Diabetes community. Through first-party data and sophisticated audience analytics, the campaign identified key community segments and delivered tailored messaging across multiple digital channels. This personalized approach ensured resonance, relevance and high engagement, making Medtronic a leader in precision healthcare marketing.
IMPACT ACHIEVED: The campaign generated outstanding results, including a 28.5% increase in website traffic, a 78.7% rise in click-through rates on search and a 15% quarter-over-quarter growth in qualified leads. Additionally, on-target conversions increased by 25%, showcasing the campaign’s success in driving meaningful action. Medtronic also surpassed industry benchmarks, achieving a 0.17% click-through rate for display ads, well above the 0.10% average. This results-driven initiative highlighted Medtronic’s ability to achieve measurable outcomes that directly impact patient and provider engagement.
DISTINCTIVE EDGE: By combining innovative technologies with behavioral insights, the campaign optimized performance while remaining agile to explore emerging channels. This pioneering approach to healthcare marketing sets a new standard for engaging niche audiences with data-driven, personalized messaging, solidifying Medtronic’s leadership in the field.